Back to search

Article

M4 drug discovery: human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist

2025-11-05

Abstract excerpt

<h4>ABSTRACT</h4> A major recent breakthrough in the treatment of type 2 diabetes has been the development of glucagon-like peptide-1 receptor agonists (GLP-1RAs). However, current translational frameworks struggle to predict the clinical outcomes of these drugs from preclinical data. There are several reasons for this struggle, which are generic for many drugs: GLP-1RAs act through multi-timescale mechanisms in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
799d4008-f154-5800-a2a2-3055176b7610
DOI
10.1101/2025.11.03.686224
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
M4 drug discovery: human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonistDOI 10.1101/2025.11.03.686224
Select a neighboring publication to make it the new centre.